Clinical Trial Update: Improving Outcomes and Quality of Life After CABG

View source ↗

Summary

An NHLBI-sponsored clinical trial completed to assess strategies for improving outcomes and quality of life after coronary artery bypass grafting (CABG).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease
• Heart Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED